{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "51991-899",
      "generic_name": "Rivastigmine",
      "labeler_name": "Breckenridge Pharmaceutical, Inc.",
      "brand_name": "Rivastigmine Transdermal System",
      "active_ingredients": [
        {
          "name": "RIVASTIGMINE",
          "strength": "13.3 mg/24h"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "51991-899-30",
          "description": "30 POUCH in 1 CARTON (51991-899-30)  / 1 PATCH in 1 POUCH (51991-899-99)  / 24 h in 1 PATCH",
          "marketing_start_date": "20191219",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Breckenridge Pharmaceutical, Inc."
        ],
        "rxcui": [
          "725021",
          "725023",
          "1308569"
        ],
        "spl_set_id": [
          "b201fe68-b5e5-4a6f-8cf1-069543f03e76"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0351991899303"
        ],
        "nui": [
          "N0000175723",
          "N0000000177"
        ],
        "pharm_class_epc": [
          "Cholinesterase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Cholinesterase Inhibitors [MoA]"
        ],
        "unii": [
          "PKI06M3IW0"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "PATCH, EXTENDED RELEASE",
      "spl_id": "6c0c606b-108e-4837-8533-f485f9e4ee4b",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "TRANSDERMAL"
      ],
      "marketing_start_date": "20191219",
      "product_id": "51991-899_6c0c606b-108e-4837-8533-f485f9e4ee4b",
      "application_number": "ANDA209063",
      "brand_name_base": "Rivastigmine Transdermal System",
      "pharm_class": [
        "Cholinesterase Inhibitor [EPC]",
        "Cholinesterase Inhibitors [MoA]"
      ]
    }
  ]
}